| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2aca75a1c3268088ecabc247e3990ad |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2006-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bbc597d5579480ac0067f7b79520f7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b216388e7b7096875d276eecbb6f3f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9503243b476002912f0551d366d33434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bb4ed449261bd830fe92223105d2558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8be648395fbab60738cffb2a9420094 |
| publicationDate |
2008-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101257921-A |
| titleOfInvention |
Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar |
| abstract |
The present invention relates to a method of treating patients with solid tumors, leukemias, and other malignancies using a combination of zosuquidar and a calicheamicin-antibody conjugate, such as Mylotarg. The invention is also directed to pharmaceutical formulations comprising zosuquidar and calicheamicin-antibody conjugates. The formulations are particularly effective in treating relapsed Acute Myelogenous Leukemia (AML) and metastatic breast cancer. |
| priorityDate |
2005-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |